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Introduction
Almost all biological phenomena involve mechanisms of
adherence. From the moment of conception to the gold medal
rewarding the olympic athlete’s performance, the myriad of
operations carried out within the organism depend on
harmonious interactions between molecules. This molecular
ballet is governed by the perfect selection of complementary
structures which fit together at the right time and at the right
place. Basically, the interactions between molecules involve
electrostatic attraction or repulsion. The strength of the
electrostatic forces decreases according to the fifth power of
the distance between the polarized components so that the
topography of the molecules determines the possibility and, in
a way, the specificity of these molecular links. At the cellular
level, binding may occur at numerous sites with a weak
adherence potential or may be mediated by only a few receptors
with a high affinity constant for their ligand.
The nature of the ligands, the modality and the precise
moment of their expression, govern the coherence of our lives.
The development of organs during embryogenesis and the
maintenance of tissue cohesion and of permanent remodelling
require the expression of cadherins and other adhesins exactly
on time; the migration of leukocytes from the bone marrow to
the peripheral regions and their movement toward inflammatory
areas are mediated by selectins, integrins and other adhesins
belonging to the Ig superfamily. Moreover, cancer and
particularly the metastatic processes also involve adherence
mechanisms.
Infectious diseases are known to start with the fixation of
a pathogen to a particular host target. Vaccination mechanisms
have benefited largely from the possibility of raising antibodies
capable of linking to these receptors to prevent the binding. In
the case of candidosis, the problem is more subtle as the fungus,
which can be found normally in the gastrointestinal tract and
usually behaves as a commensal, can also lead to lethal systemic
diseases.
Before going to the microscopic level note that candidosis
is now considered, as an emergent pathogen from an
epidemiological point of view. This assertion might appear
to be somewhat excessive since several infections such as
thrush, intertrigo, enterogastritis and others have long been
known to be due to abnormal proliferation of Candida cells.
Given the fact that Candida has a very important phenotypic
variability and that it is usually encountered in the normal
gastrointestinal flora, it becomes obvious that its so called
pathogenic behaviour comes from environmental
modifications, meaning here, imbalance of the host
surroundings. While these modifications remain superficial,
multiplication of fungi will be limited to host surfaces, held
back by an effective mucosal immunity. But in the case of an
important weakening of surface host defenses, fungal elements
may penetrate into the intimacy of tissues, blood, and spread
over in the host organism and sometimes even kill it. The
considerable increase of deep seated candidosis is mostly
observed in hospitals and particularly in intensive care units,
cancer, organ-transplant and other departments, where most
patients are subject to heavy therapeutic protocols and suffer
from immunodeficiency. Antibiotherapy, corticotherapy,
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Summary Molecules present in the most external layers of Candida cells are essential
for the adherence to host surfaces, playing a pivotal role in the pathophysiology of
candidiasis. Receptors for fibrinogen, fibronectin and other components of the
extracellular matrix have been described in Candida surfaces. Their expression may
be influenced by particular host conditions, and these changes may be important
in the transition from commensalism to pathogenicity. Surface proteins are also
essential in the interactions of the fungal cell with the various constitutive, inducible
defense host mechanisms that act during candidiasis.
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chemotherapy and catheterism are often at the origin of these
nosocomial candidosis.
The passage from a commensal to a highly pathogenic
behavior, which is rather complicated, can now be analyzed at
the molecular level, keeping in mind that all these steps are
part of a very complex, interactive network.
Candida in its “normal” habitat
As we said above, Candida cells usually participate in the
flora of the gastrointestinal tract (GIT). About 50% of normal
people have some Candida albicans in their stools among the
many bacteria which ordinarily inhabit the GIT. The normal
proliferation of these bacteria provides a barrier which
regulates the multiplication of other microorganisms such as
Candida or other potential pathogens [49]. The settlement of
these microorganisms and their harmonic development depend
on the amount of mucus, the peristaltism of the bowel, the
presence of specific IgAs and on their capacity to adhere to
epithelial cells.
The diversity of the mucus and its rapid turn-over play
an important role in limiting the multiplication of Candida
cells; their interaction with the mucus varies depending on
the type of mucin and the Candida strain [31]. Some
experiments suggest that the binding could involve
oligosaccharide and lectin-like components [21, 50].
Moreover, mucinolytic enzymes may contribute to the
virulence of C. albicans by facilitating penetration of the
mucus barrier and subsequent adherence to and invasion of
epithelial cells [13].
Secretory IgAs are known to protect the epithelium. Their
local secretion requires the presence of gut-associated lymphoid
tissues (GALT), antigen stimulation and efficient epithelial
cells. Several reports suggest the role of this Ig isotype in
protecting against mucosal candidosis [14, 48, 52, 71].
Binding to epithelial cells has been extensively studied
by numerous authors. It is obvious that this step is necessary
for the fungus prior to the penetration and colonization the
underlying tissues and blood vessels. The understanding of this
mechanism will help to develop new strategies for preventing
such proliferation. The main approaches used involve: (i)
inhibiting the fixation with identified components, (ii) analyzing
the surface constituents of non-adherent Candida cells, and
(iii) studying the role of hydrophobicity in adherence
phenomena.
Most of the results demonstrate that adhesion seems
related to surface hydrophobicity [23, 58]. The peptide
sequence of lectin-like mannoproteins of the fungal cell-wall
links to fucosyl or to N-acetyl glucosamin or galactosamin
residues belonging to the surface of the epithelial cells 
[15, 16, 19, 20, 68]; the saccharide adhesiotope seems to be
a member of the glycosphingolipid family [11, 78]. The
fungal binding structures have also been described as fimbrial
adhesins [77, 78], chitin [41] or integrin-like molecules 
[5, 27]. Candida-epithelium interaction provokes reciprocal
signaling [4]. All these studies reveal the eclectic behaviour
of Candida in providing adhesive components for epithelial
cells. 
As a commensal, Candida usually multiply by budding
when in the blastospore form. This is an important point as
Candida can switch its phenotype and produce long filaments
which seem to be associated with the beginning of a
pathogenic behaviour. This phase transition has been largely
studied taking into account that the filaments are more
adherent and secrete higher quantities of hydrolytic enzymes.
Even a slight modification can induce the phase transition.
In vivo this can be provoked by the change of the surrounding
microbiota, of the pH, of the oxygen or glucose concentration,
or can be the result of iatrogenic impacts [62]. Then the
filamentous form, which is better equipped, can bind more
strongly and even penetrate the enterocyte layer through a
kind of thigmotropism [63].
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Fig. 1 Adhesion of platelets onto the surface of Candida albicans germ
tubes
The invading Candida
Translocation of C. albicans occurs through direct penetration
of enterocytes by a unique process different from classical
phagocytosis. Translocation between enterocytes has not been
observed. Internalization is associated with a disturbance of
the plasma membrane and the brush border, but most
internalized organisms are not surrounded by a plasma
membrane. Passage of the Candida into the lamina propria
appears to be associated with disruption of the basal membrane
and extrusion of cell cytoplasm and Candida [2].
To perform all these steps, once again, Candida cell needs
different adhesins to stick to host constituents. Receptors for
many hosts proteins such as fibrinogen, fibronectin, as well as
for constituents of the extracellular matrix (ECM) have been
described. The route of the fungus is drawn by the interaction
between the substrates and the surface fungal receptors. In
addition to promote motion and settlement of the fungus, the
ability to link to host constituents could provide a kind of hiding
mechanism which protects it from recognition by the immune
system. The invasive progression of Candida can be compared
to metastatic cancer mechanisms involving both adhesin
expression and enzyme secretion. It is also important to recall
that these phenomena are dynamic and depend on the
composition of the ECM which is constantly regenerated and
differs from organ to organ.
Candida seems to express a large variety of adhesins specific
for a wide array of molecules. However, it appears that the
designation of the receptors is carelessly made by using the
name of the substrate that they bind, which is obviously
reductive. The isolation of genes coding for these adherent
molecules will certainly clarify the problem.
The following substrates have been extensively studied:
(i) Fibrinogen, which plays an important role in coagulation
processes, as well as in tissue repair and inflammatory reactions,
binds to mannoproteins of the Candida cell-wall. In vivo,
fibrinogen deposits which surround fungal elements in abscesses
have been observed in experimentally infected mice. In vitro,
purified fibrinogen was demonstrated to be principally fixed
on the germ tube surface, with a dissociation constant of 
5.2 × 10-8 M. Three cell-wall mannoprotein components of
respectively 60, 68 and > 200 kDa were identified. These factors
were shown to bind to the D fragment and to the β chain of
fibrinogen and they were also found to bind to laminin, C3d
and plastic surfaces, leading to their designation as
multifunctionnal adhesins of Candida (MFA-C) [3, 6, 7, 12,
53, 70].
(ii) Fibronectin, an adhesion promoting dimeric protein
found abundantly in connective tissue and in the basement
membrane, has also been shown to bind to surface glycoproteins
of Candida. The receptor was demonstrated to have a 
molecular mass of 60 kDa or approximately 120 kDa according
to the authors. It seems to involve an RGD adhesiotope and to
belong to the integrin family. Its expression is more important
on the germ tube surface and is increased in presence of
hemoglobin [18, 34, 38, 39, 51, 59, 60, 64, 73].
(iii) Laminin, a large basement membrane glycoprotein
[8, 43], binds to receptors closely related or similar to the
MFA-C.
(iv) Complement components which participate in many
biological activities, particularly following infection and
inflammatory reactions. Two kinds of complement receptor
(CR)-like components were evidenced on the upper surface
of the Candida cell-wall: a CR2-like component [10, 72],
and a p42-CR3-like component [1, 32]. The latter is related
to the integrin family, while the first seems to be similar to
the MFA-C.
Within the tissues the invading Candida, driven by its
binding to ECM components, quickly becomes the target for
professional phagocytes. Chemokines secreted by the fungus
or by lysed host cells and tissues, attract the phagocytes toward
the invading cells. Recognition of the fungal cell as a target
may involve different mechanisms. In the case of the
polymorphonuclears (PMN), which are the first to proceed and
whose role is prominent in limiting the progression of Candida,
several binding mechanisms have been reported. Intracellular
adhesion molecule 1 (ICAM-1) which is an IFN-γ-dependent
molecule belonging to the Ig superfamily, and selectin P and
E were shown to play an important role in fixing and engulfing
fungal elements. When they are coated by complement
components or by immunoglobulins, PMN-CRs and FcRs can
promote endocytosis. Macrophages which can operate with
similar receptors possess in addition a membrane mannose
receptor (MMR) that seems mainly involved in the capture
of Candida [35]. A β-1,2-linked tetramannose residue has been
demonstrated to be the Candida surface ligand for peritoneal
macrophages [42]. These two types of cell, PMN and
macrophages, are particularly important in the defense against
the invading Candida as qualitative or quantitative deficits are
often associated with systemic candidosis [17, 26, 33, 46, 66].
At this stage, it is important to note that the pivotal role
taken by the phagocytic cells in binding and further destroying
invading Candida cells is largely dependent on the help provided
by lymphocytes and NK cells through the secretion of cytokines,
particularly IFN-γ and TNF-α [61]. A great deal of work has
been done in this field [47, 55]. 
Translocation can drive the fungal invader into the blood
vessels. The invasion may also be due to direct contamination
following catheterism [67]. Within the blood, Candida is
rapidly coated by complement components, fibrinogen,
fibronectin, and it has been demonstrated that, prior to binding
to PMN, the fungal cells are quickly covered by platelets. The
binding may be mediated by the platelet integrin gpIIbIIIa
toward a 45 kDa mannoprotein of the Candida cell wall in
the case of resting platelets. While activated the fixation can
operate through the binding of fibrinogen and seems to be
strengthened by the externalized thrombospondin. The
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activated platelets were shown to release candidicidal peptides.
However, the aggregates resulting from the platelet fixation
can also promote the fixation of the fungus onto the
endothelium of small vessels, thus leading to a kind of
metastatic process [37, 44, 45, 54, 74–76]. Because of the
complexity of platelets and their important role in
inflammatory reactions [36], their ability to link quickly and
abundantly to Candida cells as soon as they penetrate within
the blood circulation is likely to be of great significance in
the outcome of the Candida proliferation. 
Binding to endothelial cells has also largely been studied.
It can be mediated by platelets, but in the case of direct
interaction, contrary to the case of epithelial cells, the linkage
involves protein adhesiotopes for both sides. The fungal
receptors seem to be similar to the CR-like components
previously mentioned [9, 10, 22, 65] and are likely to use an
RGD adhesiotope [40]. Endocytosis of Candida is an active
mechanism, triggered by the fungal cell but carried out by
endothelial cells [24, 25, 28]. 
Catheterism, as mentioned above, is often associated with
candidemia [29]. In addition to creating a cutaneous breach
which allows contamination, it constitutes a support within the
blood circulation which is very convenient for the binding and
proliferation of fungal cells. Moreover, once settled on a plastic
surface, the germs form a biofilm which is more resistant to
immune defenses as well as to antifungal therapy. Because of
the numerous prosthetic devices that can be introduced into the
body, the adhesion of Candida to plastic surfaces has been
carefully investigated [30, 56, 57, 69].
Conclusion
This short review, dedicated to underlining the role played
by adhesion molecules in the behavior of Candida, is obviously
reductive. If adherence phenomena are major events in these
patho-physiological processes, they should be considered as a
part of a global interplay. In vitro studies of candidal structures
are little relevant to what happens in vivo. The phase transition,
for example, which is well defined under in vitro conditions,
seems to occur quite differently while the fungus is in the bowel.
Surface components expressed on blastospores vary
dramatically with their surroundings. 
Moreover the jump from commensalism to pathogenicity
is not so clear-cut. This provides one of the great incentives to
studying host-Candida relationships. The so-called chronic
candidosis syndrome deserves to be further investigated both
from a clinical and a fundamental point of view. Until now, it
has been quite impossible to find a true candidal virulence
factor. Adhesin expression and enzyme secretion can obviously
be considered as potential virulence factors, but the level of
their synthesis and their impact in the host depend largely on
the host constitution and on its capability to react against this
potentially aggressive behavior.
Another interesting line of current work on Candida is based
on the knowledge that its pathway from commensalism to
systemic colonization must confront all the aspects of immunity.
This include surface, mucosal, humoral and cellular aspects
and all the mechanisms involved in discrimination between
self and non-self which are required to cope with this
particularly invasive cell. The dichotomy between Th1 and Th2
responses, establishing the advantage of the former in curing
mucosal candidosis, is clearly related to the capacity of
phagocytic cells to cope with the invading fungus through
adherence phenomena.
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